Acrivon Therapeutics, Inc. (ACRV)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

4

(1)

4

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
23-Aug-24 4:11 PM View:	21-Aug-24 Payment of Exercise ($731.67K)	Blume-Jensen Peter President and CEO Director		Acrivon Therapeutics, Inc. - ACRV	(8%) 2.98M to 2.74M	0	0	--	--	Show Txns Hide Txns

16-Aug-24 4:52 PM View:	14-Aug-24 Payment of Exercise ($3.44K)	Masson Kristina EVP - Business Operations Director		Acrivon Therapeutics, Inc. - ACRV	(4%) 2.94M to 2.82M	0	0	--	--	Show Txns Hide Txns

16-Aug-24 4:51 PM View:	14-Aug-24 Payment of Exercise ($2.58K)	Holm-Jorgensen Rasmus Chief Financial Officer		Acrivon Therapeutics, Inc. - ACRV	(4%) 28.06K to 26.89K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 10:00 PM View:	14-Nov-24 Payment of Exercise ($4.85K)	Devroe Eric Chief Operating Officer		Acrivon Therapeutics, Inc. - ACRV	12% 60.43K to 67.87K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 4:15 PM View:	11-Apr-24 Grant $30.00M	Ra Capital Management, LLC Director 10% Owner		Acrivon Therapeutics, Inc. - ACRV	73% 4.81M to 8.34M	0	0	--	--	Show Txns Hide Txns

15-Apr-24 8:53 AM View:	11-Apr-24 Private Purchase $20.00M	Perceptive Advisors LLC 10% Owner		Acrivon Therapeutics, Inc. - ACRV	78% 3.01M to 5.36M	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:31 PM View:	14-Nov-24 Payment of Exercise ($1.46K)	Miller Mary Chief Legal Officer		Acrivon Therapeutics, Inc. - ACRV	(8%) 41.32K to 37.94K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 10:00 PM View:	14-Nov-24 Payment of Exercise ($3.18K)	Gamelin Erick Chief Development Officer		Acrivon Therapeutics, Inc. - ACRV	(9%) 18.64K to 16.96K	0	0	--	--	Show Txns Hide Txns

18-Nov-24 4:32 PM View:	14-Nov-24 Payment of Exercise ($0.78K)	Peterson Katharine Chief Accounting Officer		Acrivon Therapeutics, Inc. - ACRV	(6%) 4.83K to 4.54K	0	0	--	--	Show Txns Hide Txns